[go: up one dir, main page]

HN2002000374A - METHODS AND COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY PATHOLOGIES - Google Patents

METHODS AND COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY PATHOLOGIES

Info

Publication number
HN2002000374A
HN2002000374A HN2002000374A HN2002000374A HN2002000374A HN 2002000374 A HN2002000374 A HN 2002000374A HN 2002000374 A HN2002000374 A HN 2002000374A HN 2002000374 A HN2002000374 A HN 2002000374A HN 2002000374 A HN2002000374 A HN 2002000374A
Authority
HN
Honduras
Prior art keywords
methods
compositions
treatment
pathologies
respiratory pathologies
Prior art date
Application number
HN2002000374A
Other languages
Spanish (es)
Inventor
Lionel Bueno
Original Assignee
Rytek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rytek filed Critical Rytek
Publication of HN2002000374A publication Critical patent/HN2002000374A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE AC OMPOSICIONES Y METODOS PARA EL TRATAMIENTO DE PATOLOGÍAS RESPIRATORIAS,SE REFIERE ADEMÁS A COMPOSICIONES Y METODOS QUE PERMITEN LA REGULACIÓN DE LA PERMEABILIDAD PARACELULAR DEL EPITELIO PULMONAR.- LAS COMPOSICIONES Y LOS METODOS DE LA INVENCIÓN ESTAN BASADOS EN PARTICULAR EN EL USO DE AGENTES O CONDICIONES QUE MODULAN LA TENSION CITOESQUELETICA DE LAS CELULAS EPITELIALES PULMONARES.- LA INVENCIÓN SE PUEDE USAR PARA TRATAMIENTOS PREVENTIVOS O CURATIVOS DE VARIAS PATOLOGÍAS COMO EL ASMA,ALERGIAS,ENFERMEDADES OBSTRUCTIVAS, ETC, EN MAMIFEROS, EN PARTICULAR, EN SERES HUMANOSTHE PRESENT INVENTION REFERS TO OMPOSITIONS AND METHODS FOR THE TREATMENT OF RESPIRATORY PATHOLOGIES, IT ALSO REFERS TO COMPOSITIONS AND METHODS THAT ALLOW THE REGULATION OF THE PARACELLULAR PERMEABILITY OF THE PULMONARY EPITHELIUM.- THE COMPOSITIONS AND THE METHODS IN THE BASED PARTICULARS OF THE INVENTION USE OF AGENTS OR CONDITIONS THAT MODULATE THE CYTOSKELETAL TENSION OF THE PULMONARY EPITHELIAL CELLS.- THE INVENTION CAN BE USED FOR PREVENTIVE OR CURATIVE TREATMENTS OF VARIOUS PATHOLOGIES SUCH AS ASTHMA, ALLERGIES, DISEASES, OBSTRUCTIVE OBSTRUCTIVES, ETC.

HN2002000374A 2001-12-21 2002-12-19 METHODS AND COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY PATHOLOGIES HN2002000374A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0116706A FR2833839A1 (en) 2001-12-21 2001-12-21 Use of pulmonary epithelial cell myosin contraction inhibitors for the treatment or prevention of respiratory disorders such as asthma, allergies, and chronic obstructive lung diseases.

Publications (1)

Publication Number Publication Date
HN2002000374A true HN2002000374A (en) 2005-06-04

Family

ID=8870864

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2002000374A HN2002000374A (en) 2001-12-21 2002-12-19 METHODS AND COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY PATHOLOGIES

Country Status (3)

Country Link
FR (1) FR2833839A1 (en)
GT (1) GT200200281A (en)
HN (1) HN2002000374A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050129679A1 (en) * 2003-12-15 2005-06-16 Nastech Pharmaceutical Company Inc. Method for opening tight junctions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2674434B1 (en) * 1991-03-27 1993-06-18 Nativelle Sa Ets NOVEL PHARMACEUTICAL COMPOSITION BASED ON TAURIN FOR INHALATION ADMINISTRATION.
AU703540B2 (en) * 1996-03-26 1999-03-25 Meddiss, Incorporated Methods for inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
AU4990599A (en) * 1998-07-14 2000-02-07 Brigham And Women's Hospital Upregulation of type iii endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization
MXPA03001468A (en) * 2000-08-15 2004-05-04 Immunex Corp Claudin polypeptides.

Also Published As

Publication number Publication date
GT200200281A (en) 2003-11-13
FR2833839A1 (en) 2003-06-27

Similar Documents

Publication Publication Date Title
AR035637A1 (en) BETAMIMETICOS OF LONG ACTION, PROCEDURE FOR ITS PREPARATION AND ITS EMPLOYMENT AS MEDICATIONS
MX2011013060A (en) Ophthalmic formulations, methods of manufacture, and methods of using same.
IL181826A0 (en) Therapeutic agents targeting the ncca-atp channel and methods of use thereof
BRPI0400670A (en) Unmixed Hair Relaxation Formulations & Hair Straightening Methods
ITRM20030210A1 (en) PROSTHESIS TO BE USED IN THE PROLASSO SURGICAL THERAPY
AR034660A1 (en) NEBULIZER FOR THE APPLICATION OF LIQUIDS ON THE EYE CORNEA
ECSP10010310A (en) NEW COMPOUNDS AND COMPOSITIONS AND METHODS OF USE
NO20070561L (en) Compositions and Methods for Treating Eye Diseases and Conditions.
NI201000093A (en) TOWEL TO WEAR
UY27872A1 (en) CASPASA INHIBITORS AND USES OF THE SAME.
EP2359832A3 (en) Therapeutic agents targeting the NCCA-ATP channel and methods of use thereof
WO2003072593A3 (en) Bone targeting peptides
BRPI0803568B8 (en) mucoadhesive composition
BR0117009A (en) Compositions for use in the treatment of ige associated disorders
PL2446878T3 (en) Tromethamine ketorolac compositions for use in the treatment or prevention of ocular pain
TR200400526T4 (en) Lipoxin A4 and analogues for the treatment of dry eye
UY26889A1 (en) PHARMACEUTICAL COMPOUNDS
NZ708821A (en) Lfa-1 inhibitor formulations
BR0210013A (en) Pyrenzepine Ophthalmic Gel
CO6592098A2 (en) Stable formulation of mia / cd-rap
BRPI0517435A (en) triazoles useful as protein kinase inhibitors
UY27589A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY PATHOLOGIES
CY1118967T1 (en) HIGH-DOSE BIOTINE PHARMACEUTICAL COMPOSITIONS
SI1988909T1 (en) Use of polyethylene glycol in inflammation related topical disorders or diseases and wound healing
AR028772A1 (en) 5-AMINOALQUIL-PIRAZOL [4,3-D] PYRIMIDINS